Suppr超能文献

接种三种不同的甲型/苏联/92/77(H1N1)灭活流感病毒疫苗后人体中的E玫瑰花结形成细胞和体液抗体滴度

E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).

作者信息

Schmidt S, Süss J, Oehring H, Schmidt J

出版信息

Acta Virol. 1982 Dec;26(6):466-73.

PMID:6132540
Abstract

The number of E-rosette forming cells and the serum haemagglutination inhibition (HI) antibody titres were examined in 37 volunteers immediately before and 14, 28, 35 and 63 days after immunization with three inactivated influenza virus vaccines A/USSR/92/77 (H1N1)--NIB 6 and in 11 non-vaccinated controls. From the former, 10 volunteers were immunized with 1000 haemagglutinin (HA) IU per dose, 11 volunteers with the NIB 6 adsorbate vaccine (340 HA IU/dose) and 16 volunteers with a bivalent vaccine composed of 180 HA IU/dose NIB 6 and 180 HA IU/dose of influenza virus A/Bangkok X-73 (H3N2). The percentage of E-rosette forming cells was decreased in all vaccinated volunteers 14 days after vaccination; later on the values reached normal level of non-vaccinated controls or of subjects before vaccination. The number of E-rosette forming cells was in correlation with the applied virus vaccine dose, i.e. for the 1000 HA IU/dose: 29.95 +/- 11.74%, p less than 0.001 and for the 340 HA IU/dose: 47.75 +/- 11.15%, p less than 0.005; however, after administration of 180 HA IU/dose of NIB 6 in the bivalent vaccine, the value 58.65 +/- 11.5% was not significantly decreased in comparison to non-vaccinated donors. The serum HI antibody titres reached the highest level 14 days after vaccination and remained constant during the next 6 weeks. There was a correlation between decreased E-rosette values and increased serum antibody titres (p less than 0.05). The current study indicates that the number of E-rosette forming cells may serve as a further laboratory criterion for controlling the effect of inactivated influenza virus vaccines on the immune system of man.

摘要

在37名志愿者接种三种灭活流感病毒疫苗A/USSR/92/77(H1N1)-NIB 6之前以及接种后14、28、35和63天,检测了E-玫瑰花结形成细胞数量和血清血凝抑制(HI)抗体滴度,并设置了11名未接种疫苗的对照。在前者中,10名志愿者接种每剂1000血凝素(HA)国际单位的疫苗,11名志愿者接种NIB 6吸附疫苗(340 HA国际单位/剂),16名志愿者接种由180 HA国际单位/剂NIB 6和180 HA国际单位/剂甲型流感病毒A/曼谷X-73(H3N2)组成的二价疫苗。接种疫苗14天后,所有接种志愿者的E-玫瑰花结形成细胞百分比均下降;随后这些值达到未接种疫苗对照或接种前受试者的正常水平。E-玫瑰花结形成细胞数量与所应用的病毒疫苗剂量相关,即对于1000 HA国际单位/剂:29.95±11.74%,p<0.001;对于340 HA国际单位/剂:47.75±11.15%,p<0.005;然而,在二价疫苗中接种180 HA国际单位/剂的NIB 6后,与未接种疫苗的供体相比,58.65±11.5%的值没有显著下降。血清HI抗体滴度在接种疫苗14天后达到最高水平,并在接下来的6周内保持稳定。E-玫瑰花结值降低与血清抗体滴度升高之间存在相关性(p<0.05)。当前研究表明,E-玫瑰花结形成细胞数量可作为控制灭活流感病毒疫苗对人体免疫系统作用效果的进一步实验室标准。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验